Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)

Clinical trial NCT00543959 · TERMINATED

Trial details

NCT number: NCT00543959
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2006-06-01
Primary completion: 2007-08-01
Enrollment: 346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.